Craig Penz

1.2k total citations
6 papers, 71 citations indexed

About

Craig Penz is a scholar working on Molecular Biology, Clinical Biochemistry and Neurology. According to data from OpenAlex, Craig Penz has authored 6 papers receiving a total of 71 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Clinical Biochemistry and 1 paper in Neurology. Recurrent topics in Craig Penz's work include Porphyrin Metabolism and Disorders (4 papers), Metabolism and Genetic Disorders (2 papers) and Boron Compounds in Chemistry (1 paper). Craig Penz is often cited by papers focused on Porphyrin Metabolism and Disorders (4 papers), Metabolism and Genetic Disorders (2 papers) and Boron Compounds in Chemistry (1 paper). Craig Penz collaborates with scholars based in United States, Sweden and United Kingdom. Craig Penz's co-authors include Amy Simon, Farrah Pompilus, William Querbes, Patrick Marquis, Sonalee Agarwal, Jae Bum Kim, Pauline Harper, Eliane Sardh, Gary Liu and Mathew S. Maurer and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Journal of Hepatology.

In The Last Decade

Craig Penz

5 papers receiving 69 citations

Peers

Countries citing papers authored by Craig Penz

Since Specialization

Citations

This map shows the geographic impact of Craig Penz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Penz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Penz more than expected).

Fields of papers citing papers by Craig Penz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Penz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Penz. The network helps show where Craig Penz may publish in the future.

Co-authorship network of co-authors of Craig Penz

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Penz. A scholar is included among the top collaborators of Craig Penz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Penz. Craig Penz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Characterizing trajectories of diabetes-related health parameters before diabetes diagnosis in diabetes subtypes: analysis of a 20-year long prospective cohort study in Sweden 2025 ·Cardiovascular Diabetology ·(unknown), (unknown), Emma Ahlqvist, Olof Asplund, Craig Penz, (unknown), (unknown), Anton Lager, Boel Brynedal, (unknown), (unknown), (unknown)	0
2	A phase 1/2 open label extension study of givosiran, an investigational RNAi therapeutic, in patients with acute intermittent porphyria 2020 ·Journal of Hepatology ·Penelope E. Stein, D. Rees, Karl E. Anderson, Herbert L. Bonkovsky, Eliane Sardh, Pauline Harper, Manisha Balwani, (unknown), J. P. Phillips, Daphne Vassiliou, Craig Penz, (unknown), Gary Liu, Amy Simon, D. Montgomery Bissell	9
3	Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations 2018 ·Patient ·Amy Simon, Farrah Pompilus, William Querbes, (unknown), (unknown), Craig Penz, (unknown), (unknown), Jae Bum Kim, Sonalee Agarwal, Patrick Marquis	51
4	A phase 1/2, randomized, placebo controlled and open label extension studies of Givosiran and investigational RNA interference therapeutic, in patients with acute intermittent porphyria 2018 ·Journal of Hepatology ·Eliane Sardh, Manisha Balwani, Pauline Harper, Peter Stein, (unknown), Jackie C. Bloomer, D. Montgomery Bissell, (unknown), Jane Phillips, Herbert L. Bonkovsky, Robert J. Desnick, Nabil Al‐Tawil, Stephanie Rock, Craig Penz, Anthony W.H. Chan, William Querbes, Amy Simon, Kelly E. Anderson	3
5	Interim Data from a Randomized, Placebo Controlled, Phase 1 Study of Aln-AS1, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyria 2016 ·Blood ·Eliane Sardh, Pauline Harper, Nabil Al‐Tawil, Manisha Balwani, Karl E. Anderson, Joseph R. Bloomer, (unknown), Robert J. Desnick, Charles J. Parker, John D. Phillips, Herbert L. Bonkovsky, Craig Penz, Amy Chan, Chang-Heok Soh, William Querbes, Amy Simon, Penelope E. Stein, David C. Rees	2
6	A PHASE 2, MULTI-CENTER, OPEN-LABEL TRIAL TO EVALUATE THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS AND EXPLORATORY CLINICAL ACTIVITY OF ALN-TTRSC, AN RNAI THERAPEUTIC FOR THE TREATMENT OF PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS 2015 ·Journal of the American College of Cardiology ·Julian D. Gillmore, Rodney H. Falk, Mathew S. Maurer, Michael G. Hanna, Verena Karsten, Craig Penz, Tracy Zimmermann, Jared Gollob, Philip N. Hawkins	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact